Ovid Therapeutics Inc. (OVID) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 120.19M |
| Enterprise Value | 120.46M |
| P/E Ratio | -7.87 |
| PEG Ratio | 87.84 |
| Price/Sales Ratio | 330.13 |
| Price/Book Ratio | 2.63 |
| Enterprise/Revenue | 331 |
| Enterprise/EBITDA | -15.23 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -21.79 |
| Operating Margin | -36.87 |
| Return On Assets | -0.15 |
| Return On Equity | -0.24 |
| Revenue | 7.25M |
| Revenue/Share | 0.01 |
| Gross Profit | 6.95M |
| EBITDA | -17.11M |
| Net Income | -17.41M |
| Diluted EPS | -0.24 |
| Total Cash | 117.22M |
| Total Cash/Share | 0.59 |
| Total Debt | 12.72M |
| Total Debt/Equity | 0.06 |
| Current Ratio | 12.39 |
| Book Value Per Share | 1.06 |
| 52-Week Change | 145.61 |
| 52-Week High | 3.11 |
| 52-Week Low | 1.05 |
| Moving Average 50 Days | 2.52 |
| Moving Average 200 Days | 2.12 |
| Average Volume | 2.31M |
| Shares Outstanding | 186.64M |
| % Held by Institutions | 142.49 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |